Stockholm Stock Exchange | Mid Cap
Camurus
+25.40%
Latest
+19.43%
3 months
Pareto SecuritiesNordea MarketsCarnegieDNBJefferiesHandelsbankenDNB Markets

Price Targets For Camurus

AnalystPrice TargetDateUpside
Pareto Securities315 SEKNov -22
+25.40%
Nordea Markets305 SEKNov -22
Carnegie280 SEKNov -22
DNB310 SEKSep -22
Jefferies205 SEKApr -22
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia